Cargando…
Cancer and COVID-19 — potentially deleterious effects of delaying radiotherapy
Radiotherapy can be safely delivered during the coronavirus disease 2019 (COVID-19) pandemic, often through use of hypofractionated regimens, which minimize the number of visits to treatment centres while also avoiding potentially detrimental delays in the delivery of cancer care.
Autores principales: | Nagar, Himanshu, Formenti, Silvia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184542/ https://www.ncbi.nlm.nih.gov/pubmed/32341524 http://dx.doi.org/10.1038/s41571-020-0375-1 |
Ejemplares similares
-
Cancer diagnostic delay in the COVID-19 era: what happens next?
por: Hamilton, William
Publicado: (2020) -
Effect of COVID-19 restrictions on thyroid cytopathology: delay in the diagnosis of indeterminate lesions
por: Rossi, Esther Diana, et al.
Publicado: (2023) -
Acute tolerance of Moderna mRNA-1273 vaccine against COVID-19 in patients with cancer treated with radiotherapy
por: Scoccianti, Silvia, et al.
Publicado: (2021) -
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
por: Ng, Kenrick, et al.
Publicado: (2020) -
Initiation of the Global Coalition for Radiotherapy during the COVID-19 pandemic
por: Price, Pat, et al.
Publicado: (2020)